Chemours (CC) Financials

$11.12 -0.40 (-3.43%)

Closing price 04/15/2025 03:59 PM Eastern

Extended Trading

$10.94 -0.19 (-1.71%)

As of 04/15/2025 07:33 PM Eastern

Annual Income Statements for Chemours

This table shows Chemours' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	400	-90	7.00	746	995	-52	219	608	578	-238	86
Consolidated Net Income / (Loss)	401	-90	7.00	747	996	-52	219	608	578	-237	86
Net Income / (Loss) Continuing Operations	401	-90	7.00	747	996	-52	219	608	578	-237	86
Total Pre-Tax Income	550	-188	-11	912	1,155	-124	179	676	741	-318	127
Total Operating Income	511	-132	-94	981	1,183	348	367	676	772	-245	341
Total Gross Profit	1,360	955	1,103	1,745	1,971	1,063	1,067	1,381	1,616	1,306	1,151
Total Revenue	6,432	5,717	5,400	6,183	6,638	5,526	4,969	6,345	6,831	6,078	5,782
Operating Revenue	6,432	5,717	5,400	6,183	6,638	5,526	4,969	6,345	6,831	6,078	5,782
Total Cost of Revenue	5,072	4,762	4,297	4,438	4,667	4,463	3,902	4,964	5,215	4,772	4,631
Operating Cost of Revenue	5,072	4,762	4,297	4,438	4,667	4,463	3,902	4,964	5,215	4,772	4,631
Total Operating Expenses	849	1,087	1,197	764	788	715	700	705	844	1,551	810
Selling, General & Admin Expense	685	632	946	626	657	548	527	592	710	1,290	585
Research & Development Expense	143	97	81	81	82	80	93	107	118	108	109
Impairment Charge	0.00	358	-	-	-	-	-	-	0.00	0.00	56
Restructuring Charge	21	-	170	57	49	87	80	6.00	16	153	60
Total Other Income / (Expense), net	39	-56	83	-69	-28	-472	-188	0.00	-31	-73	-214
Interest Expense	0.00	132	213	215	233	208	232	206	156	209	265
Interest & Investment Income	20	22	29	33	43	29	23	43	55	45	43
Other Income / (Expense), net	19	54	267	113	162	-293	21	163	70	91	8.00
Income Tax Expense	149	-98	-18	165	159	-72	-40	68	163	-81	41
Net Income / (Loss) Attributable to Noncontrolling Interest	1.00	0.00	0.00	1.00	1.00	-	-	0.00	0.00	1.00	0.00
Basic Earnings per Share	$2.21	($0.50)	$0.04	$4.04	$5.62	($0.32)	$1.33	$3.69	$3.72	($1.60)	$0.58
Weighted Average Basic Shares Outstanding	180.97M	180M	183.15M	184.84M	176.97M	164.01M	165.17M	160.02M	148.34M	148.80M	149.44M
Diluted Earnings per Share	$2.21	($0.50)	$0.04	$3.91	$5.45	($0.32)	$1.32	$3.60	$3.65	($1.60)	$0.57
Weighted Average Diluted Shares Outstanding	180.97M	180M	183.15M	184.84M	176.97M	164.01M	165.17M	160.02M	148.34M	148.80M	149.44M
Weighted Average Basic & Diluted Shares Outstanding	180.97M	180M	183.15M	184.84M	176.97M	164.01M	165.17M	160.02M	148.34M	148.80M	149.44M
Cash Dividends to Common per Share	$0.00	$0.58	$0.12	$0.29	$0.67	$1.00	$1.00	$1.00	$1.00	$1.00	$1.00

This table shows Chemours' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	240	-97	145	-376	12	-19	52	70	-27	-9.00
Consolidated Net Income / (Loss)	240	-97	145	-376	12	-18	52	70	-27	-9.00
Net Income / (Loss) Continuing Operations	240	-97	145	-376	12	-18	52	70	-27	-9.00
Total Pre-Tax Income	299	-69	173	-433	13	-71	67	82	-30	8.00
Total Operating Income	261	-10	202	-396	-46	-5.00	112	138	21	70
Total Gross Profit	432	201	368	410	273	255	286	306	286	273
Total Revenue	1,777	1,375	1,536	1,643	1,487	1,412	1,350	1,538	1,501	1,393
Operating Revenue	1,777	1,375	1,536	1,643	1,487	1,412	1,350	1,538	1,501	1,393
Total Cost of Revenue	1,345	1,174	1,168	1,233	1,214	1,157	1,064	1,232	1,215	1,120
Operating Cost of Revenue	1,345	1,174	1,168	1,233	1,214	1,157	1,064	1,232	1,215	1,120
Total Operating Expenses	171	211	166	806	319	260	174	168	265	203
Selling, General & Admin Expense	140	175	124	779	165	222	142	139	135	169
Research & Development Expense	32	31	26	28	28	26	28	26	29	26
Restructuring Charge	-1.00	5.00	16	-1.00	126	12	4.00	3.00	45	8.00
Total Other Income / (Expense), net	38	-59	-29	-37	59	-66	-45	-56	-51	-62
Interest Expense	34	41	42	48	56	63	63	66	69	67
Interest & Investment Income	16	12	12	13	13	7.00	13	11	11	8.00
Other Income / (Expense), net	56	-30	1.00	-2.00	102	-10	5.00	-1.00	7.00	-3.00
Income Tax Expense	59	28	28	-57	1.00	-53	15	12	-3.00	17
Basic Earnings per Share	$1.54	($0.57)	$0.97	($2.52)	$0.08	($0.13)	$0.35	$0.47	($0.18)	($0.06)
Weighted Average Basic Shares Outstanding	150.92M	148.34M	149.16M	148.08M	148.44M	148.80M	148.90M	149.27M	149.41M	149.44M
Diluted Earnings per Share	$1.52	($0.56)	$0.96	($2.52)	$0.08	($0.12)	$0.34	$0.46	($0.18)	($0.05)
Weighted Average Diluted Shares Outstanding	150.92M	148.34M	149.16M	148.08M	148.44M	148.80M	148.90M	149.27M	149.41M	149.44M
Weighted Average Basic & Diluted Shares Outstanding	150.92M	148.34M	149.16M	148.08M	148.44M	148.80M	148.90M	149.27M	149.41M	149.44M

This table details how cash moves in and out of Chemours' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	0.00	366	536	622	-340	-258	124	480	-215	503	-1,044
Net Cash From Operating Activities	505	182	594	640	1,140	650	807	814	755	556	-633
Net Cash From Continuing Operating Activities	505	310	594	640	1,140	650	807	814	755	556	-633
Net Income / (Loss) Continuing Operations	401	-90	7.00	747	996	-52	219	608	578	-237	86
Consolidated Net Income / (Loss)	401	-90	7.00	747	996	-52	219	608	578	-237	86
Depreciation Expense	257	267	284	273	284	311	320	317	291	307	301
Amortization Expense	0.00	8.00	16	13	11	9.00	9.00	9.00	9.00	9.00	12
Non-Cash Adjustments To Reconcile Net Income	-39	215	-148	-82	6.00	411	45	-82	-19	14	89
Changes in Operating Assets and Liabilities, net	-114	-218	435	-311	-157	-29	214	-38	-104	463	-1,121
Net Cash From Investing Activities	-560	-497	357	-370	-487	-483	-234	220	-284	-229	-353
Net Cash From Continuing Investing Activities	-560	-497	357	-370	-487	-483	-234	220	-284	-229	-353
Purchase of Property, Plant & Equipment	-604	-519	-338	-411	-498	-481	-267	-277	-307	-370	-360
Purchase of Investments	-	-	-12	-	-	-2.00	27	-12	3.00	-8.00	2.00
Sale of Property, Plant & Equipment	32	12	708	39	46	9.00	5.00	508	33	143	3.00
Other Investing Activities, net	20	-	-	0.00	-	1.00	1.00	1.00	-13	6.00	2.00
Net Cash From Financing Activities	55	687	-396	352	-993	-419	-449	-554	-686	172	-36
Net Cash From Continuing Financing Activities	0.00	687	-396	352	-993	-419	-449	-554	-686	172	-36
Repayment of Debt	0.00	-89	-385	-7.00	-720	-187	-448	-883	-69	-284	-478
Repurchase of Common Equity	-	-	0.00	-106	-644	-322	0.00	-173	-495	-69	0.00
Payment of Dividends	0.00	-105	-22	-22	-148	-164	-168	-165	-155	-148	-149
Issuance of Debt	0.00	3,491	0.00	0.00	520	278	312	650	0.00	648	606
Other Financing Activities, net	0.00	-2,610	11	487	-1.00	-24	-145	17	33	25	-15
Cash Interest Paid	0.00	103	208	208	206	204	208	180	164	223	267
Cash Income Taxes Paid	0.00	53	50	79	75	85	78	149	131	54	73

This table details how cash moves in and out of Chemours' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	52	-95	-283	-76	511	351	-454	-734	50	94
Net Cash From Operating Activities	301	161	-124	67	131	482	-290	-620	139	138
Net Cash From Continuing Operating Activities	301	161	-124	67	131	482	-290	-620	139	138
Net Income / (Loss) Continuing Operations	241	-97	145	-376	11	-17	52	69	-27	-8.00
Consolidated Net Income / (Loss)	241	-97	145	-376	11	-17	52	69	-27	-8.00
Depreciation Expense	71	74	79	78	76	74	71	74	78	78
Amortization Expense	3.00	2.00	2.00	2.00	2.00	3.00	3.00	3.00	3.00	3.00
Non-Cash Adjustments To Reconcile Net Income	-13	25	3.00	-9.00	-30	50	-16	-5.00	73	37
Changes in Operating Assets and Liabilities, net	-1.00	157	-353	372	72	372	-400	-761	12	28
Net Cash From Investing Activities	-74	-65	-97	-60	58	-130	-101	-70	-75	-107
Net Cash From Continuing Investing Activities	-74	-65	-97	-60	58	-130	-101	-70	-75	-107
Purchase of Property, Plant & Equipment	-72	-67	-91	-58	-86	-135	-102	-73	-76	-109
Purchase of Investments	2.00	2.00	-6.00	6.00	-8.00	-	-2.00	1.00	1.00	2.00
Net Cash From Financing Activities	-175	-191	-68	-79	324	-5.00	-54	-40	-27	85
Net Cash From Continuing Financing Activities	-175	-191	-68	-79	324	-5.00	-54	-40	-27	85
Repayment of Debt	-57	-4.00	-3.00	-3.00	-275	-3.00	-3.00	-2.00	13	-486
Payment of Dividends	-39	-38	-37	-38	-37	-36	-37	-37	-38	-37
Issuance of Debt	-	-	-	-	-	-	-	-	-	606
Other Financing Activities, net	-	-5.00	-14	-2.00	6.00	35	-14	-1.00	-2.00	2.00

This table presents Chemours' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	5,959	6,298	3,822	7,293	7,362	7,258	7,082	7,550	7,640	8,251	7,515
Total Current Assets	1,941	2,301	902	3,493	3,293	2,777	2,633	3,345	3,214	3,835	3,026
Cash & Equivalents	0.00	366	902	1,556	1,201	943	1,105	1,451	1,102	1,203	713
Restricted Cash	-	-	-	-	-	-	-	-	0.00	604	0.00
Accounts Receivable	846	859	-	919	861	674	511	720	626	610	770
Inventories, net	1,052	972	-	935	1,147	1,079	939	1,099	1,404	1,352	1,472
Prepaid Expenses	43	104	-	83	84	81	78	75	82	66	71
Plant, Property, & Equipment, net	3,308	3,177	2,784	3,008	3,291	3,559	3,474	3,154	3,171	3,216	3,183
Plant, Property & Equipment, gross	9,282	9,015	-	8,511	8,992	9,413	9,582	9,232	9,387	9,412	9,572
Accumulated Depreciation	5,974	5,838	-	5,503	5,701	5,854	6,108	6,078	6,216	6,196	6,389
Total Noncurrent Assets	710	820	136	792	778	922	975	1,051	1,255	1,200	1,306
Long-Term Investments	124	136	136	173	160	162	167	169	175	158	152
Goodwill	198	176	-	166	181	153	153	102	102	102	46
Intangible Assets	11	-	-	-	-	21	14	6.00	13	3.00	3.00
Other Noncurrent Operating Assets	377	508	-	453	437	586	641	674	763	937	1,055
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	100	202	0.00	50
Total Liabilities & Shareholders' Equity	5,959	6,298	0.00	7,293	7,362	7,258	7,082	7,550	7,640	8,251	7,515
Total Liabilities	2,286	6,168	0.00	6,428	6,342	6,563	6,267	6,468	6,533	7,512	6,910
Total Current Liabilities	1,398	1,466	0.00	1,648	1,709	1,541	1,442	1,858	1,891	2,486	1,803
Short-Term Debt	0.00	39	-	15	13	134	21	25	43	51	54
Accounts Payable	1,046	973	-	1,075	1,137	923	844	1,162	1,233	1,159	1,142
Accrued Expenses	352	454	-	558	559	484	375	498	494	1,187	508
Current Employee Benefit Liabilities	-	-	-	-	-	-	107	173	121	89	99
Total Noncurrent Liabilities	888	4,702	0.00	4,780	4,633	5,022	4,825	4,610	4,642	5,026	5,107
Long-Term Debt	0.00	3,915	-	4,097	3,959	4,026	4,005	3,724	3,590	3,987	4,054
Asset Retirement Reserve & Litigation Obligation	-	-	-	-	-	-	295	389	474	461	456
Noncurrent Deferred & Payable Income Tax Liabilities	424	234	-	208	217	118	36	49	61	44	35
Other Noncurrent Operating Liabilities	464	553	-	475	457	878	489	448	517	534	562
Commitments & Contingencies	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3,673	130	0.00	865	1,020	695	815	1,082	1,107	739	605
Total Preferred & Common Equity	3,669	126	0.00	860	1,014	689	813	1,081	1,107	737	604
Total Common Equity	3,669	126	0.00	860	1,014	689	813	1,081	1,107	737	604
Common Stock	0.00	777	-	839	862	861	892	946	1,018	1,035	1,057
Retained Earnings	0.00	-115	-	579	1,466	1,249	1,303	1,746	2,170	1,782	1,718
Treasury Stock	-	-	-	-116	-750	-1,072	-1,072	-1,247	-1,738	-1,806	-1,804
Accumulated Other Comprehensive Income / (Loss)	19	-536	-	-442	-564	-349	-310	-364	-343	-274	-367
Noncontrolling Interest	4.00	4.00	-	5.00	6.00	6.00	2.00	1.00	0.00	2.00	1.00

This table presents Chemours' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	7,745	7,624	7,660	7,948	7,978	7,249	7,463
Total Current Assets	3,543	3,202	3,374	3,683	3,597	2,937	3,080
Cash & Equivalents	1,167	816	738	852	746	604	596
Restricted Cash	-	-	207	595	607	15	20
Accounts Receivable	980	837	890	846	792	896	951
Inventories, net	1,321	1,486	1,446	1,314	1,391	1,368	1,438
Prepaid Expenses	75	63	64	76	61	54	75
Plant, Property, & Equipment, net	3,071	3,180	3,190	3,119	3,209	3,157	3,173
Plant, Property & Equipment, gross	9,186	9,499	9,548	9,243	9,469	9,440	9,545
Accumulated Depreciation	6,115	6,319	6,358	6,124	6,260	6,283	6,372
Total Noncurrent Assets	1,131	1,242	1,096	1,146	1,172	1,155	1,210
Long-Term Investments	186	185	189	192	165	169	190
Goodwill	102	102	102	102	102	102	46
Intangible Assets	15	10	8.00	5.00	3.00	3.00	3.00
Other Noncurrent Operating Assets	627	740	797	847	902	881	921
Other Noncurrent Nonoperating Assets	201	205	0.00	0.00	-	-	50
Total Liabilities & Shareholders' Equity	7,745	7,624	7,660	7,948	7,978	7,249	7,463
Total Liabilities	6,460	6,396	6,850	7,191	7,224	6,524	6,804
Total Current Liabilities	1,951	1,745	2,190	2,195	2,231	1,557	1,777
Short-Term Debt	24	25	25	23	41	37	53
Accounts Payable	1,270	1,166	1,009	901	963	938	1,069
Accrued Expenses	527	471	1,078	1,177	1,148	509	566
Current Employee Benefit Liabilities	130	83	78	94	79	73	89
Total Noncurrent Liabilities	4,509	4,651	4,660	4,996	4,993	4,967	5,027
Long-Term Debt	3,510	3,599	3,604	3,944	3,968	3,951	3,988
Asset Retirement Reserve & Litigation Obligation	482	477	473	467	452	453	448
Noncurrent Deferred & Payable Income Tax Liabilities	53	60	58	54	44	41	41
Other Noncurrent Operating Liabilities	464	515	525	531	529	522	550
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,285	1,228	810	757	754	725	659
Total Preferred & Common Equity	1,284	1,227	808	755	752	723	657
Total Common Equity	1,284	1,227	808	755	752	723	657
Common Stock	1,017	1,006	1,016	1,032	1,035	1,047	1,052
Retained Earnings	2,304	2,278	1,864	1,845	1,797	1,828	1,763
Treasury Stock	-1,604	-1,751	-1,790	-1,807	-1,806	-1,805	-1,805
Accumulated Other Comprehensive Income / (Loss)	-433	-306	-282	-315	-274	-347	-353
Noncontrolling Interest	1.00	1.00	2.00	2.00	2.00	2.00	2.00

This table displays calculated financial ratios and metrics derived from Chemours' official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.23%	-11.12%	-5.54%	14.50%	7.36%	-16.75%	-10.08%	27.69%	7.66%	-11.02%	-4.87%
EBITDA Growth	-3.44%	-74.97%	140.10%	191.75%	18.84%	-77.13%	91.20%	62.48%	-1.97%	-85.81%	308.64%
EBIT Growth	-4.33%	-114.72%	321.79%	532.37%	22.94%	-95.91%	605.45%	116.24%	0.36%	-118.29%	326.62%
NOPAT Growth	-4.50%	-124.80%	28.79%	1,321.15%	26.96%	-76.12%	84.32%	35.41%	-0.96%	-128.48%	234.64%
Net Income Growth	-5.42%	-122.44%	107.78%	10,571.43%	33.33%	-105.22%	521.15%	177.63%	-4.93%	-141.00%	136.29%
EPS Growth	-5.56%	-122.62%	108.00%	9,675.00%	39.39%	-105.87%	512.50%	172.73%	1.39%	-143.84%	135.63%
Operating Cash Flow Growth	-36.72%	-63.96%	226.37%	7.74%	78.13%	-42.98%	24.15%	0.87%	-7.25%	-26.36%	-213.85%
Free Cash Flow Firm Growth	0.00%	96.05%	683.89%	-53.63%	87.66%	-80.44%	405.63%	69.20%	-57.58%	-38.63%	-372.10%
Invested Capital Growth	0.00%	0.93%	-22.28%	16.67%	11.79%	3.28%	-4.83%	-12.83%	4.82%	-13.77%	35.06%
Revenue Q/Q Growth	0.00%	0.00%	-0.70%	4.25%	-1.63%	-1.99%	-0.28%	3.86%	-2.83%	1.23%	0.56%
EBITDA Q/Q Growth	0.00%	0.00%	-24.56%	64.29%	-5.26%	-62.24%	227.40%	25.95%	-24.77%	19.12%	14.93%
EBIT Q/Q Growth	0.00%	0.00%	-47.73%	97.83%	-6.40%	-91.92%	455.96%	41.01%	-30.76%	13.97%	30.71%
NOPAT Q/Q Growth	0.00%	0.00%	-163.14%	126.55%	-9.38%	-44.51%	136.70%	14.51%	-25.26%	2.00%	-45.89%
Net Income Q/Q Growth	0.00%	0.00%	-95.36%	158.48%	-7.95%	-112.75%	285.59%	53.92%	-36.27%	25.00%	11.69%
EPS Q/Q Growth	0.00%	0.00%	-95.06%	167.81%	-6.36%	-113.28%	294.12%	54.51%	-34.59%	21.57%	14.00%
Operating Cash Flow Q/Q Growth	0.00%	-51.08%	-5.11%	5.44%	-3.72%	27.70%	-5.50%	-15.12%	-5.86%	136.60%	-119.03%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	118.08%	0.54%	1,281.75%	1.66%	-2.56%	-32.38%	5,450.00%	-127.24%
Invested Capital Q/Q Growth	0.00%	0.00%	-7.20%	1.53%	-1.63%	-9.00%	-3.31%	-0.54%	-0.12%	-8.85%	-1.20%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	21.14%	16.70%	20.43%	28.22%	29.69%	19.24%	21.47%	21.77%	23.66%	21.49%	19.91%
EBITDA Margin	12.24%	3.45%	8.76%	22.32%	24.71%	6.79%	14.43%	18.36%	16.72%	2.67%	11.45%
Operating Margin	7.94%	-2.31%	-1.74%	15.87%	17.82%	6.30%	7.39%	10.65%	11.30%	-4.03%	5.90%
EBIT Margin	8.24%	-1.36%	3.20%	17.69%	20.26%	1.00%	7.81%	13.22%	12.33%	-2.53%	6.04%
Profit (Net Income) Margin	6.23%	-1.57%	0.13%	12.08%	15.00%	-0.94%	4.41%	9.58%	8.46%	-3.90%	1.49%
Tax Burden Percent	72.91%	47.87%	-63.64%	81.91%	86.23%	41.94%	122.35%	89.94%	78.00%	74.53%	67.72%
Interest Burden Percent	103.77%	241.03%	-6.36%	83.36%	85.87%	-225.45%	46.13%	80.57%	88.00%	206.49%	36.39%
Effective Tax Rate	27.09%	0.00%	0.00%	18.09%	13.77%	0.00%	-22.35%	10.06%	22.00%	0.00%	32.28%
Return on Invested Capital (ROIC)	21.00%	-2.59%	-2.07%	26.64%	29.66%	6.60%	12.27%	18.20%	18.90%	-5.65%	6.99%
ROIC Less NNEP Spread (ROIC-NNEP)	-24.87%	-2.45%	0.27%	24.45%	28.69%	-3.83%	4.35%	18.20%	17.74%	-8.75%	1.48%
Return on Net Nonoperating Assets (RNNOA)	0.84%	-2.14%	12.84%	146.08%	76.02%	-12.66%	16.74%	45.90%	33.91%	-20.03%	5.81%
Return on Equity (ROE)	21.84%	-4.73%	10.77%	172.72%	105.68%	-6.06%	29.01%	64.10%	52.81%	-25.68%	12.80%
Cash Return on Invested Capital (CROIC)	-179.00%	-3.52%	23.00%	11.26%	18.52%	3.38%	17.22%	31.92%	14.19%	9.14%	-22.85%
Operating Return on Assets (OROA)	8.89%	-1.27%	3.42%	19.69%	18.36%	0.75%	5.41%	11.47%	11.09%	-1.94%	4.43%
Return on Assets (ROA)	6.73%	-1.47%	0.14%	13.44%	13.59%	-0.71%	3.05%	8.31%	7.61%	-2.98%	1.09%
Return on Common Equity (ROCE)	21.81%	-4.72%	10.44%	171.72%	105.06%	-6.02%	28.85%	64.00%	52.79%	-25.65%	12.77%
Return on Equity Simple (ROE_SIMPLE)	10.93%	-71.43%	0.00%	86.86%	98.22%	-7.55%	26.94%	56.24%	52.21%	-32.16%	14.24%
Net Operating Profit after Tax (NOPAT)	373	-92	-66	804	1,020	244	449	608	602	-172	231
NOPAT Margin	5.79%	-1.62%	-1.22%	13.00%	15.37%	4.41%	9.04%	9.58%	8.82%	-2.82%	3.99%
Net Nonoperating Expense Percent (NNEP)	45.86%	-0.14%	-2.33%	2.19%	0.97%	10.43%	7.92%	0.00%	1.16%	3.10%	5.50%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	12.70%	-3.59%	4.90%
Cost of Revenue to Revenue	78.86%	83.30%	79.57%	71.78%	70.31%	80.76%	78.53%	78.23%	76.34%	78.51%	80.09%
SG&A Expenses to Revenue	10.65%	11.05%	17.52%	10.12%	9.90%	9.92%	10.61%	9.33%	10.39%	21.22%	10.12%
R&D to Revenue	2.22%	1.70%	1.50%	1.31%	1.24%	1.45%	1.87%	1.69%	1.73%	1.78%	1.89%
Operating Expenses to Revenue	13.20%	19.01%	22.17%	12.36%	11.87%	12.94%	14.09%	11.11%	12.36%	25.52%	14.01%
Earnings before Interest and Taxes (EBIT)	530	-78	173	1,094	1,345	55	388	839	842	-154	349
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	787	197	473	1,380	1,640	375	717	1,165	1,142	162	662
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	5.85	0.00	8.31	3.75	3.56	4.42	4.60	3.86	6.08	4.18
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	10.30	4.56	4.76	5.56	5.11	4.31	7.09	4.55
Price to Revenue (P/Rev)	0.00	0.13	0.57	1.16	0.57	0.44	0.72	0.78	0.63	0.74	0.44
Price to Earnings (P/E)	0.00	0.00	441.40	9.58	3.82	0.00	16.40	8.18	7.40	0.00	29.36
Dividend Yield	0.00%	14.24%	0.71%	0.31%	3.78%	6.67%	4.58%	3.28%	3.53%	3.31%	5.92%
Earnings Yield	0.00%	0.00%	0.23%	10.43%	26.17%	0.00%	6.10%	12.22%	13.52%	0.00%	3.41%
Enterprise Value to Invested Capital (EV/IC)	0.00	1.17	0.74	2.94	1.77	1.47	1.78	2.28	2.03	2.33	1.52
Enterprise Value to Revenue (EV/Rev)	0.00	0.73	0.38	1.54	0.97	1.00	1.28	1.12	0.97	1.08	1.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	21.29	4.34	6.91	3.91	14.70	8.85	6.10	5.81	40.46	8.71
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	11.86	8.72	4.77	100.23	16.36	8.47	7.88	0.00	16.53
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	11.87	6.29	22.63	14.14	11.69	11.01	0.00	24.98
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	23.04	3.45	14.90	5.63	8.48	7.87	8.73	8.78	11.79	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	2.80	28.09	10.07	44.24	10.07	6.67	14.67	23.62	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	30.42	0.00	4.75	3.89	5.99	4.94	3.46	3.28	5.46	6.79
Long-Term Debt to Equity	0.00	30.12	0.00	4.74	3.88	5.79	4.91	3.44	3.24	5.40	6.70
Financial Leverage	-0.03	0.88	47.97	5.97	2.65	3.30	3.85	2.52	1.91	2.29	3.92
Leverage Ratio	1.62	3.22	77.85	12.85	7.77	8.52	9.50	7.71	6.94	8.61	11.73
Compound Leverage Factor	1.68	7.77	-4.95	10.71	6.68	-19.22	4.38	6.21	6.11	17.78	4.27
Debt to Total Capital	0.00%	96.82%	0.00%	82.62%	79.57%	85.68%	83.16%	77.60%	76.65%	84.53%	87.16%
Short-Term Debt to Total Capital	0.00%	0.95%	0.00%	0.30%	0.26%	2.76%	0.43%	0.52%	0.91%	1.07%	1.15%
Long-Term Debt to Total Capital	0.00%	95.86%	0.00%	82.32%	79.31%	82.92%	82.73%	77.09%	75.74%	83.46%	86.02%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.11%	0.10%	0.00%	0.10%	0.12%	0.12%	0.04%	0.02%	0.00%	0.04%	0.02%
Common Equity to Total Capital	99.89%	3.09%	0.00%	17.28%	20.31%	14.19%	16.79%	22.38%	23.35%	15.43%	12.82%
Debt to EBITDA	0.00	20.07	0.00	2.98	2.42	11.09	5.62	3.22	3.18	24.93	6.21
Net Debt to EBITDA	0.00	17.52	0.00	1.73	1.59	8.15	3.84	1.83	2.06	12.80	4.90
Long-Term Debt to EBITDA	0.00	19.87	0.00	2.97	2.41	10.74	5.59	3.20	3.14	24.61	6.12
Debt to NOPAT	0.00	-42.79	0.00	5.12	3.89	17.08	8.97	6.17	6.03	-23.55	17.79
Net Debt to NOPAT	0.00	-37.36	0.00	2.97	2.56	12.54	6.13	3.50	3.91	-12.09	14.04
Long-Term Debt to NOPAT	0.00	-42.37	0.00	5.10	3.88	16.53	8.92	6.13	5.96	-23.25	17.56
Altman Z-Score	0.00	1.07	0.00	2.42	2.40	1.46	1.69	2.23	2.26	1.53	1.66
Noncontrolling Interest Sharing Ratio	0.11%	0.21%	3.08%	0.58%	0.58%	0.70%	0.53%	0.16%	0.05%	0.11%	0.22%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.39	1.57	0.00	2.12	1.93	1.80	1.83	1.80	1.70	1.54	1.68
Quick Ratio	0.61	0.84	0.00	1.50	1.21	1.05	1.12	1.17	0.91	0.73	0.82
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-3,176	-125	732	340	637	125	630	1,066	452	278	-755
Operating Cash Flow to CapEx	88.29%	35.90%	0.00%	172.04%	252.21%	137.71%	308.02%	0.00%	275.55%	244.93%	-177.31%
Free Cash Flow to Firm to Interest Expense	0.00	-0.95	3.44	1.58	2.73	0.60	2.72	5.17	2.90	1.33	-2.85
Operating Cash Flow to Interest Expense	0.00	1.38	2.79	2.98	4.89	3.13	3.48	3.95	4.84	2.66	-2.39
Operating Cash Flow Less CapEx to Interest Expense	0.00	-2.46	4.53	1.25	2.95	0.86	2.35	5.07	3.08	1.57	-3.74
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.08	0.93	1.07	1.11	0.91	0.76	0.69	0.87	0.90	0.77	0.73
Accounts Receivable Turnover	7.60	6.71	0.00	0.00	7.46	7.20	8.39	10.31	10.15	9.84	8.38
Inventory Turnover	4.82	4.71	0.00	0.00	4.48	4.01	3.87	4.87	4.17	3.46	3.28
Fixed Asset Turnover	1.94	1.76	1.81	2.14	2.11	1.61	1.41	1.91	2.16	1.90	1.81
Accounts Payable Turnover	4.85	4.72	0.00	0.00	4.22	4.33	4.42	4.95	4.35	3.99	4.03
Days Sales Outstanding (DSO)	48.01	54.43	0.00	0.00	48.94	50.69	43.52	35.41	35.96	37.11	43.56
Days Inventory Outstanding (DIO)	75.71	77.57	0.00	0.00	81.42	91.03	94.38	74.93	87.59	105.40	111.29
Days Payable Outstanding (DPO)	75.27	77.38	0.00	0.00	86.50	84.24	82.64	73.75	83.81	91.48	90.68
Cash Conversion Cycle (CCC)	48.44	54.62	0.00	0.00	43.85	57.48	55.26	36.58	39.74	51.03	64.17
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,549	3,582	2,784	3,248	3,631	3,750	3,569	3,111	3,261	2,812	3,798
Invested Capital Turnover	3.62	1.60	1.70	2.05	1.93	1.50	1.36	1.90	2.14	2.00	1.75
Increase / (Decrease) in Invested Capital	3,549	33	-798	464	383	119	-181	-458	150	-449	986
Enterprise Value (EV)	0.00	4,193	2,052	9,538	6,419	5,512	6,347	7,105	6,632	6,555	5,769
Market Capitalization	0.00	737	3,090	7,150	3,802	2,451	3,591	4,975	4,276	4,480	2,525
Book Value per Share	$20.27	$0.70	$0.00	$4.64	$5.93	$4.21	$4.94	$6.63	$7.34	$4.97	$4.04
Tangible Book Value per Share	$19.12	($0.28)	$0.00	$3.75	$4.87	$3.15	$3.93	$5.97	$6.57	$4.26	$3.71
Total Capital	3,673	4,084	0.00	4,977	4,992	4,855	4,841	4,831	4,740	4,777	4,713
Total Debt	0.00	3,954	0.00	4,112	3,972	4,160	4,026	3,749	3,633	4,038	4,108
Total Long-Term Debt	0.00	3,915	0.00	4,097	3,959	4,026	4,005	3,724	3,590	3,987	4,054
Net Debt	-124	3,452	-1,038	2,383	2,611	3,055	2,754	2,129	2,356	2,073	3,243
Capital Expenditures (CapEx)	572	507	-370	372	452	472	262	-231	274	227	357
Debt-free, Cash-free Net Working Capital (DFCFNWC)	543	508	0.00	304	396	427	107	61	264	-407	564
Debt-free Net Working Capital (DFNWC)	543	874	902	1,860	1,597	1,370	1,212	1,512	1,366	1,400	1,277
Net Working Capital (NWC)	543	835	902	1,845	1,584	1,236	1,191	1,487	1,323	1,349	1,223
Net Nonoperating Expense (NNE)	-28	-2.40	-73	57	24	296	230	0.00	24	66	145
Net Nonoperating Obligations (NNO)	-124	3,452	2,784	2,383	2,611	3,055	2,754	2,029	2,154	2,073	3,193
Total Depreciation and Amortization (D&A)	257	275	300	286	295	320	329	326	300	316	313
Debt-free, Cash-free Net Working Capital to Revenue	8.44%	8.89%	0.00%	4.92%	5.97%	7.73%	2.15%	0.96%	3.86%	-6.70%	9.75%
Debt-free Net Working Capital to Revenue	8.44%	15.29%	16.70%	30.08%	24.06%	24.79%	24.39%	23.83%	20.00%	23.03%	22.09%
Net Working Capital to Revenue	8.44%	14.61%	16.70%	29.84%	23.86%	22.37%	23.97%	23.44%	19.37%	22.19%	21.15%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($0.50)	$0.04	$4.04	$5.62	($0.32)	$1.33	$3.69	$3.72	($1.60)	$0.58
Adjusted Weighted Average Basic Shares Outstanding	180.97M	181.38M	183.15M	182.52M	167.04M	164.01M	165.17M	160.02M	148.34M	148.80M	149.44M
Adjusted Diluted Earnings per Share	$0.00	($0.50)	$0.04	$3.91	$5.45	($0.32)	$1.32	$3.60	$3.65	($1.60)	$0.57
Adjusted Weighted Average Diluted Shares Outstanding	180.97M	181.38M	183.15M	182.52M	167.04M	164.01M	165.17M	160.02M	148.34M	148.80M	149.44M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.04	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	180.97M	181.38M	183.15M	182.52M	167.04M	164.01M	165.17M	160.02M	148.34M	148.80M	149.44M
Normalized Net Operating Profit after Tax (NOPAT)	388	158	53	850	1,062	305	313	613	615	-64	309
Normalized NOPAT Margin	6.03%	2.77%	0.99%	13.75%	16.00%	5.51%	6.30%	9.67%	9.00%	-1.06%	5.35%
Pre Tax Income Margin	8.55%	-3.29%	-0.20%	14.75%	17.40%	-2.24%	3.60%	10.65%	10.85%	-5.23%	2.20%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	-0.59	0.81	5.09	5.77	0.26	1.67	4.07	5.40	-0.74	1.32
NOPAT to Interest Expense	0.00	-0.70	-0.31	3.74	4.38	1.17	1.94	2.95	3.86	-0.82	0.87
EBIT Less CapEx to Interest Expense	0.00	-4.43	2.55	3.36	3.83	-2.00	0.54	5.19	3.64	-1.82	-0.03
NOPAT Less CapEx to Interest Expense	0.00	-4.54	1.43	2.01	2.44	-1.10	0.81	4.07	2.10	-1.91	-0.48
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	-116.67%	314.29%	2.95%	14.86%	-315.38%	76.71%	27.14%	26.82%	-62.45%	173.26%
Augmented Payout Ratio	0.00%	-116.67%	314.29%	17.14%	79.52%	-934.62%	76.71%	55.59%	112.46%	-91.56%	173.26%

This table displays calculated financial ratios and metrics derived from Chemours' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.77%	-12.64%	-12.93%	-14.20%	-16.32%	2.69%	-12.11%	-6.39%	0.94%	-1.35%
EBITDA Growth	7.12%	-91.26%	-26.42%	-196.66%	-65.73%	72.22%	-32.75%	167.30%	-18.66%	138.71%
EBIT Growth	11.62%	-111.98%	-34.52%	-256.08%	-82.33%	62.50%	-42.36%	134.42%	-50.00%	546.67%
NOPAT Growth	-17.16%	-104.44%	-33.36%	-246.81%	-120.27%	50.00%	-48.66%	142.50%	134.62%	-2,150.00%
Net Income Growth	12.15%	-141.81%	-38.03%	-287.06%	-95.00%	81.44%	-64.14%	118.62%	-325.00%	50.00%
EPS Growth	19.69%	-140.88%	-32.87%	-300.00%	-94.74%	78.57%	-64.58%	118.25%	-325.00%	58.33%
Operating Cash Flow Growth	-3.22%	-22.60%	-6,300.00%	-76.98%	-56.48%	199.38%	-133.87%	-1,025.37%	6.11%	-71.37%
Free Cash Flow Firm Growth	-91.11%	-125.50%	-101.91%	-146.88%	89.71%	383.76%	5,712.44%	-189.95%	-641.16%	-339.00%
Invested Capital Growth	4.38%	4.82%	5.13%	-2.79%	-5.51%	-13.77%	-11.00%	19.81%	24.60%	35.06%
Revenue Q/Q Growth	-7.21%	-22.62%	14.80%	6.97%	-9.49%	-5.04%	-0.81%	13.93%	-2.41%	-7.20%
EBITDA Q/Q Growth	18.85%	-90.79%	688.89%	-211.97%	142.14%	-53.73%	267.31%	12.04%	-49.07%	35.78%
EBIT Q/Q Growth	24.31%	-112.62%	607.50%	-296.06%	114.07%	-126.79%	568.00%	17.09%	-79.56%	139.29%
NOPAT Q/Q Growth	10.95%	-103.34%	2,518.66%	-263.73%	84.68%	91.76%	927.86%	35.52%	-87.52%	-635.71%
Net Income Q/Q Growth	19.40%	-140.42%	249.48%	-359.31%	103.19%	-250.00%	300.00%	34.62%	-138.57%	66.67%
EPS Q/Q Growth	20.63%	-136.84%	271.43%	-362.50%	103.17%	-250.00%	300.00%	35.29%	-139.13%	72.22%
Operating Cash Flow Q/Q Growth	3.44%	-46.51%	-177.02%	154.03%	95.52%	267.94%	-159.92%	-113.79%	122.42%	-0.72%
Free Cash Flow Firm Q/Q Growth	-81.45%	-316.56%	94.46%	-2,007.29%	175.08%	223.91%	11.27%	-208.87%	-40.12%	-43.05%
Invested Capital Q/Q Growth	-3.12%	-0.12%	11.81%	-10.15%	-5.83%	-8.85%	15.40%	20.96%	-2.06%	-1.20%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	24.31%	14.62%	23.96%	24.95%	18.36%	18.06%	21.19%	19.90%	19.05%	19.60%
EBITDA Margin	22.00%	2.62%	18.49%	-19.35%	9.01%	4.39%	14.15%	13.91%	7.26%	10.62%
Operating Margin	14.69%	-0.73%	13.15%	-24.10%	-3.09%	-0.35%	8.30%	8.97%	1.40%	5.03%
EBIT Margin	17.84%	-2.91%	13.22%	-24.22%	3.77%	-1.06%	8.67%	8.91%	1.87%	4.81%
Profit (Net Income) Margin	13.51%	-7.05%	9.44%	-22.89%	0.81%	-1.27%	3.85%	4.55%	-1.80%	-0.65%
Tax Burden Percent	80.27%	140.58%	83.82%	86.84%	92.31%	25.35%	77.61%	85.37%	90.00%	-112.50%
Interest Burden Percent	94.32%	172.50%	85.22%	108.79%	23.21%	473.33%	57.27%	59.85%	-107.14%	11.94%
Effective Tax Rate	19.73%	0.00%	16.19%	0.00%	7.69%	0.00%	22.39%	14.63%	0.00%	212.50%
Return on Invested Capital (ROIC)	25.93%	-1.09%	20.35%	-31.96%	-5.40%	-0.50%	10.92%	12.20%	1.63%	-9.89%
ROIC Less NNEP Spread (ROIC-NNEP)	27.41%	-5.39%	19.32%	-36.23%	-2.87%	-1.18%	9.49%	10.52%	0.11%	-7.24%
Return on Net Nonoperating Assets (RNNOA)	49.32%	-10.31%	38.06%	-82.68%	-6.06%	-2.71%	23.51%	38.81%	0.44%	-28.37%
Return on Equity (ROE)	75.25%	-11.40%	58.41%	-114.64%	-11.46%	-3.20%	34.43%	51.02%	2.06%	-38.26%
Cash Return on Invested Capital (CROIC)	20.92%	14.19%	9.52%	4.03%	0.16%	9.14%	4.83%	-10.98%	-9.59%	-22.85%
Operating Return on Assets (OROA)	16.42%	-2.62%	11.46%	-19.81%	2.88%	-0.81%	6.49%	6.85%	1.39%	3.53%
Return on Assets (ROA)	12.43%	-6.34%	8.18%	-18.72%	0.62%	-0.98%	2.88%	3.50%	-1.34%	-0.47%
Return on Common Equity (ROCE)	75.18%	-11.40%	58.36%	-114.47%	-11.44%	-3.20%	34.37%	50.88%	2.06%	-38.18%
Return on Equity Simple (ROE_SIMPLE)	70.64%	0.00%	39.85%	-10.89%	-41.85%	0.00%	-43.88%	16.04%	11.72%	0.00%
Net Operating Profit after Tax (NOPAT)	209	-7.00	169	-277	-42	-3.50	87	118	15	-79
NOPAT Margin	11.79%	-0.51%	11.02%	-16.87%	-2.86%	-0.25%	6.44%	7.66%	0.98%	-5.65%
Net Nonoperating Expense Percent (NNEP)	-1.48%	4.30%	1.03%	4.28%	-2.53%	0.69%	1.42%	1.69%	1.51%	-2.65%
Return On Investment Capital (ROIC_SIMPLE)	-	-0.15%	-	-	-	-0.07%	-	-	-	-1.67%
Cost of Revenue to Revenue	75.69%	85.38%	76.04%	75.05%	81.64%	81.94%	78.81%	80.10%	80.95%	80.40%
SG&A Expenses to Revenue	7.88%	12.73%	8.07%	47.41%	11.10%	15.72%	10.52%	9.04%	8.99%	12.13%
R&D to Revenue	1.80%	2.25%	1.69%	1.70%	1.88%	1.84%	2.07%	1.69%	1.93%	1.87%
Operating Expenses to Revenue	9.62%	15.35%	10.81%	49.06%	21.45%	18.41%	12.89%	10.92%	17.65%	14.57%
Earnings before Interest and Taxes (EBIT)	317	-40	203	-398	56	-15	117	137	28	67
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	391	36	284	-318	134	62	191	214	109	148
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.77	3.86	3.42	6.49	5.28	6.08	5.08	4.58	4.62	4.18
Price to Tangible Book Value (P/TBV)	3.05	4.31	3.76	7.51	6.15	7.09	5.90	5.36	4.99	4.55
Price to Revenue (P/Rev)	0.51	0.63	0.64	0.83	0.66	0.74	0.65	0.58	0.53	0.44
Price to Earnings (P/E)	3.92	7.40	8.58	0.00	0.00	0.00	0.00	28.82	39.91	29.36
Dividend Yield	4.36%	3.53%	3.54%	2.85%	3.71%	3.31%	3.89%	4.49%	4.92%	5.92%
Earnings Yield	25.49%	13.52%	11.66%	0.00%	0.00%	0.00%	0.00%	3.47%	2.51%	3.41%
Enterprise Value to Invested Capital (EV/IC)	1.76	2.03	1.87	2.36	2.05	2.33	1.95	1.66	1.63	1.52
Enterprise Value to Revenue (EV/Rev)	0.82	0.97	1.04	1.23	1.05	1.08	1.08	1.14	1.09	1.00
Enterprise Value to EBITDA (EV/EBITDA)	3.78	5.81	6.56	19.69	46.45	40.46	91.50	10.84	10.89	8.71
Enterprise Value to EBIT (EV/EBIT)	4.72	7.88	9.28	94.39	0.00	0.00	0.00	22.09	23.48	16.53
Enterprise Value to NOPAT (EV/NOPAT)	7.12	11.01	13.19	193.98	0.00	0.00	0.00	25.69	14.69	24.98
Enterprise Value to Operating Cash Flow (EV/OCF)	7.16	8.78	10.84	19.11	26.88	11.79	16.19	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	8.58	14.67	20.13	57.80	1,263.34	23.62	37.92	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.75	3.28	2.95	4.48	5.24	5.46	5.32	5.50	6.13	6.79
Long-Term Debt to Equity	2.73	3.24	2.93	4.45	5.21	5.40	5.26	5.45	6.05	6.70
Financial Leverage	1.80	1.91	1.97	2.28	2.11	2.29	2.48	3.69	3.89	3.92
Leverage Ratio	6.69	6.94	6.32	7.60	7.69	8.61	7.87	9.71	10.88	11.73
Compound Leverage Factor	6.31	11.97	5.39	8.27	1.78	40.75	4.51	5.81	-11.66	1.40
Debt to Total Capital	73.33%	76.65%	74.69%	81.75%	83.98%	84.53%	84.17%	84.62%	85.98%	87.16%
Short-Term Debt to Total Capital	0.50%	0.91%	0.52%	0.56%	0.49%	1.07%	0.86%	0.79%	1.13%	1.15%
Long-Term Debt to Total Capital	72.84%	75.74%	74.18%	81.19%	83.49%	83.46%	83.31%	83.83%	84.85%	86.02%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.02%	0.00%	0.02%	0.05%	0.04%	0.04%	0.04%	0.04%	0.04%	0.02%
Common Equity to Total Capital	26.64%	23.35%	25.29%	18.20%	15.98%	15.43%	15.79%	15.34%	13.98%	12.82%
Debt to EBITDA	2.33	3.18	3.48	9.23	29.17	24.93	58.10	6.64	7.02	6.21
Net Debt to EBITDA	1.44	2.06	2.52	6.35	17.12	12.80	36.10	5.32	5.62	4.90
Long-Term Debt to EBITDA	2.31	3.14	3.46	9.17	29.00	24.61	57.51	6.57	6.92	6.12
Debt to NOPAT	4.39	6.03	7.01	90.95	-22.67	-23.55	-17.10	15.72	9.47	17.79
Net Debt to NOPAT	2.71	3.91	5.08	62.53	-13.30	-12.09	-10.62	12.61	7.58	14.04
Long-Term Debt to NOPAT	4.36	5.96	6.96	90.33	-22.54	-23.25	-16.92	15.58	9.35	17.56
Altman Z-Score	2.04	1.88	1.99	1.64	1.66	1.59	1.62	1.74	1.59	1.53
Noncontrolling Interest Sharing Ratio	0.09%	0.05%	0.08%	0.15%	0.15%	0.11%	0.15%	0.26%	0.28%	0.22%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.82	1.70	1.84	1.54	1.68	1.54	1.61	1.89	1.73	1.68
Quick Ratio	1.10	0.91	0.95	0.74	0.77	0.73	0.69	0.96	0.87	0.82
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	72	-157	-8.69	-183	138	446	488	-531	-744	-1,065
Operating Cash Flow to CapEx	418.06%	240.30%	-136.26%	101.52%	0.00%	370.77%	-292.93%	-849.32%	182.89%	126.61%
Free Cash Flow to Firm to Interest Expense	2.13	-3.83	-0.21	-3.82	2.46	7.07	7.74	-8.05	-10.79	-15.89
Operating Cash Flow to Interest Expense	8.85	3.93	-2.95	1.40	2.34	7.65	-4.60	-9.39	2.01	2.06
Operating Cash Flow Less CapEx to Interest Expense	6.74	2.29	-5.12	0.02	3.41	5.59	-6.17	-10.50	0.91	0.43
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.92	0.90	0.87	0.82	0.77	0.77	0.75	0.77	0.75	0.73
Accounts Receivable Turnover	7.76	10.15	7.09	6.44	6.58	9.84	7.17	6.42	6.40	8.38
Inventory Turnover	4.47	4.17	3.82	3.66	3.61	3.46	3.21	3.28	3.36	3.28
Fixed Asset Turnover	2.27	2.16	2.08	2.00	1.94	1.90	1.83	1.81	1.83	1.81
Accounts Payable Turnover	4.43	4.35	4.34	4.33	4.38	3.99	4.34	4.74	4.69	4.03
Days Sales Outstanding (DSO)	47.01	35.96	51.45	56.72	55.50	37.11	50.90	56.82	57.04	43.56
Days Inventory Outstanding (DIO)	81.67	87.59	95.50	99.60	101.20	105.40	113.72	111.26	108.78	111.29
Days Payable Outstanding (DPO)	82.30	83.81	84.05	84.39	83.38	91.48	84.15	76.98	77.87	90.68
Cash Conversion Cycle (CCC)	46.38	39.74	62.90	71.93	73.32	51.03	80.46	91.10	87.95	64.17
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,265	3,261	3,646	3,276	3,085	2,812	3,245	3,925	3,844	3,798
Invested Capital Turnover	2.20	2.14	1.85	1.89	1.89	2.00	1.70	1.59	1.66	1.75
Increase / (Decrease) in Invested Capital	137	150	178	-94	-180	-449	-401	649	759	986
Enterprise Value (EV)	5,740	6,632	6,818	7,740	6,317	6,555	6,313	6,517	6,270	5,769
Market Capitalization	3,558	4,276	4,194	5,243	3,987	4,480	3,820	3,315	3,033	2,525
Book Value per Share	$8.28	$7.34	$8.27	$5.42	$5.10	$4.97	$5.05	$4.86	$4.40	$4.04
Tangible Book Value per Share	$7.52	$6.57	$7.52	$4.68	$4.38	$4.26	$4.35	$4.15	$4.07	$3.71
Total Capital	4,819	4,740	4,852	4,439	4,724	4,777	4,763	4,713	4,700	4,713
Total Debt	3,534	3,633	3,624	3,629	3,967	4,038	4,009	3,988	4,041	4,108
Total Long-Term Debt	3,510	3,590	3,599	3,604	3,944	3,987	3,968	3,951	3,988	4,054
Net Debt	2,181	2,356	2,623	2,495	2,328	2,073	2,491	3,200	3,235	3,243
Capital Expenditures (CapEx)	72	67	91	66	-60	130	99	73	76	109
Debt-free, Cash-free Net Working Capital (DFCFNWC)	449	264	666	264	64	-407	54	798	740	564
Debt-free Net Working Capital (DFNWC)	1,616	1,366	1,482	1,209	1,511	1,400	1,407	1,417	1,356	1,277
Net Working Capital (NWC)	1,592	1,323	1,457	1,184	1,488	1,349	1,366	1,380	1,303	1,223
Net Nonoperating Expense (NNE)	-31	90	24	99	-54	15	35	48	42	-70
Net Nonoperating Obligations (NNO)	1,980	2,154	2,418	2,466	2,328	2,073	2,491	3,200	3,185	3,193
Total Depreciation and Amortization (D&A)	74	76	81	80	78	77	74	77	81	81
Debt-free, Cash-free Net Working Capital to Revenue	6.39%	3.86%	10.14%	4.19%	1.07%	-6.70%	0.92%	13.91%	12.87%	9.75%
Debt-free Net Working Capital to Revenue	22.99%	20.00%	22.57%	19.21%	25.17%	23.03%	24.09%	24.70%	23.58%	22.09%
Net Working Capital to Revenue	22.65%	19.37%	22.19%	18.81%	24.78%	22.19%	23.39%	24.06%	22.66%	21.15%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.54	($0.57)	$0.97	($2.52)	$0.13	($0.13)	$0.35	$0.47	($0.18)	($0.06)
Adjusted Weighted Average Basic Shares Outstanding	150.92M	148.34M	149.16M	148.08M	148.44M	148.80M	148.90M	149.27M	149.41M	149.44M
Adjusted Diluted Earnings per Share	$1.52	($0.56)	$0.96	($2.52)	$0.13	($0.12)	$0.34	$0.46	($0.18)	($0.05)
Adjusted Weighted Average Diluted Shares Outstanding	150.92M	148.34M	149.16M	148.08M	148.44M	148.80M	148.90M	149.27M	149.41M	149.44M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	150.92M	148.34M	149.16M	148.08M	148.44M	148.80M	148.90M	149.27M	149.41M	149.44M
Normalized Net Operating Profit after Tax (NOPAT)	209	-3.50	183	-278	74	4.90	90	120	85	55
Normalized NOPAT Margin	11.74%	-0.25%	11.90%	-16.91%	4.97%	0.35%	6.67%	7.83%	5.69%	3.92%
Pre Tax Income Margin	16.83%	-5.02%	11.26%	-26.35%	0.87%	-5.03%	4.96%	5.33%	-2.00%	0.57%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.32	-0.98	4.83	-8.29	1.00	-0.24	1.86	2.08	0.41	1.00
NOPAT to Interest Expense	6.16	-0.17	4.03	-5.78	-0.76	-0.06	1.38	1.78	0.21	-1.18
EBIT Less CapEx to Interest Expense	7.21	-2.61	2.67	-9.67	2.07	-2.30	0.29	0.97	-0.70	-0.63
NOPAT Less CapEx to Interest Expense	4.04	-1.80	1.86	-7.15	0.31	-2.12	-0.19	0.68	-0.89	-2.80
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	17.42%	26.82%	31.08%	-172.73%	-47.47%	-62.45%	-44.85%	126.72%	192.21%	173.26%
Augmented Payout Ratio	66.37%	112.46%	105.73%	-484.09%	-114.87%	-91.56%	-61.52%	142.24%	192.21%	173.26%

Frequently Asked Questions About Chemours' Financials

When does Chemours's financial year end?

According to the most recent income statement we have on file, Chemours' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Chemours' net income changed over the last 10 years?

Chemours' net income appears to be on a downward trend, with a most recent value of $86 million in 2024, falling from $401 million in 2014. The previous period was -$237 million in 2023.

What is Chemours's operating income?

Chemours's total operating income in 2024 was $341 million, based on the following breakdown:

Total Gross Profit: $1.15 billion
Total Operating Expenses: $810 million

How has Chemours revenue changed over the last 10 years?

Over the last 10 years, Chemours' total revenue changed from $6.43 billion in 2014 to $5.78 billion in 2024, a change of -10.1%.

How much debt does Chemours have?

Chemours' total liabilities were at $6.91 billion at the end of 2024, a 8.0% decrease from 2023, and a 202.3% increase since 2014.

How much cash does Chemours have?

In the past 10 years, Chemours' cash and equivalents has ranged from $0.00 in 2014 to $1.56 billion in 2017, and is currently $713 million as of their latest financial filing in 2024.

How has Chemours' book value per share changed over the last 10 years?

Over the last 10 years, Chemours' book value per share changed from 20.27 in 2014 to 4.04 in 2024, a change of -80.1%.

Remove Ads

Related Companies

This page (NYSE:CC) was last updated on 4/16/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Chemours (CC) Financials

Frequently Asked Questions About Chemours' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Chemours (CC) Financials

Annual Income Statements for Chemours

Quarterly Income Statements for Chemours

Annual Cash Flow Statements for Chemours

Quarterly Cash Flow Statements for Chemours

Annual Balance Sheets for Chemours

Quarterly Balance Sheets for Chemours

Annual Metrics and Ratios for Chemours

Quarterly Metrics and Ratios for Chemours

Frequently Asked Questions About Chemours' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools